Research and analysis

Shingles immunisation programme [Shingrix®]: evaluation reports

Evaluation of the Shingrix® herpes zoster (shingles) vaccination programme in England: academic years 2023/24, 2024/25 and 2025/26.

• From: UK Health Security Agency
• Published: 29 August 2024
• Last updated: 28 May 2026
  Show all updates

  1. 28 May 2026

     Added the HPR 20(5) report, the second quarterly report for the academic year 2025/26, and the associated data file.

  2. 1 May 2026

     Annual report for 2024/25 (with suffix "updated version 2") substituted fror original version. (Version 2 includes data from both GP IT suppliers; first version took account of data from only 57.9% of GPs.)

  3. 2 April 2026

     Added latest quarterly report and associated data file.

  4. 3 March 2026

     Added data file associated with the annual report for 2024/25.

  5. 26 February 2026

     Added annual report for academic year 2024/25.

  6. 31 October 2025

     Added the HPR 19(10) report, the third quarterly report for the academic year 2024/25, and the associated data file.

  7. 31 July 2025

     Added the HPR 19(7) report, the second quarterly report for the academic year 2024/25, and the associated data file.

  8. 24 April 2025

     Added the HPR 19(4) report, the first quarterly report for the academic year 2024/2025, and the associated data file.

  9. 30 January 2025

     Added quarterly report for Q3 of epidemiological year 2023/24.

  10. 26 September 2024

      Added quarterly report and data file for Q2 of epidemiological year 2023/24.

  11. 29 August 2024

      First published.

Applies to England

Documents

Shingrix vaccine coverage report (adults eligible from September 2025 to February 2026 and vaccinated to the end of April 2026): England

Ref: HPR 20(5)

HTML

Shingrix vaccine uptake and coverage report (September 2025 to February 2026, measured at 23 April 2026)

Ref: HPR 20(5)

MS Excel Spreadsheet, 376 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles uptake and coverage report (adults eligible September 2025 to November 2025 and vaccinated to end of January 2026): England

Ref: HPR 20(3)

HTML

Shingrix vaccine uptake and coverage report (September 2025 to November 2025, measured at 23 January 2026)

Ref: HPR 20(3)

MS Excel Spreadsheet, 347 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage in England: annual report September 2024 to August 2025 (updated version 2)

Ref: HPR 20(4)

HTML

Shingrix vaccine uptake and coverage report from 1 September 2024 to 31 August 2025, measured at 23 October 2025

Ref: HPR 20(2)

MS Excel Spreadsheet, 309 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingrix vaccine uptake and coverage report from 1 September 2024 to 31 August 2025, measured at 23 October 2025

Ref: HPR 20(2)

MS Excel Spreadsheet, 324 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine uptake report (adults eligible from September 2024 to May 2025 and vaccinated to the end of July 2025): England

Ref: HPR 19(10)

HTML

Shingrix® vaccine coverage by ICB and LA (England), September 2024 to May 2025 (vaccinated to the end of July 2025)

Ref: HPR 19(10)

MS Excel Spreadsheet, 219 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine uptake report (adults eligible from September 2024 to February 2025 and vaccinated to the end of April 2025): England

Ref: HPR 19(7)

HTML

Shingrix® vaccine coverage by ICB and LA (England), September 2024 to February 2025 (vaccinated to the end of April 2025)

Ref: HPR 19(7)

MS Excel Spreadsheet, 252 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage report (adults eligible from September to November 2024 and vaccinated to the end of January 2025): England

Ref: HPR 19(4)

HTML

Shingrix® vaccine coverage by ICB and LA (England), September to November 2024 (vaccinated to the end of January 2025)

Ref: HPR 19(4)

MS Excel Spreadsheet, 298 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingrix® vaccine uptake report (adults eligible from September 2023 to August 2024 and vaccinated to the end of October 2024): England

Ref: HPR 19(1)

HTML

Shingrix® vaccine uptake report (adults eligible from September 2023 to May 2024 and vaccinated to the end of July 2024): England

Ref: HPR 18(8)

HTML

Shingrix® vaccine coverage by ICB and LA (England), 1 March 2023 to 31 May 2024 (vaccinated to 23 July 2024)

Ref: HPR 18(8)

MS Excel Spreadsheet, 89.6 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingrix® vaccine uptake report (adults eligible from September 2023 to February 2024 and vaccinated to the end of April 2024): England

Ref: HPR 18(7)

HTML

Shingrix® vaccine coverage by ICB and LA (England), September 2023 to February 2024 (vaccinated to end-April 2024)

Ref: HPR 18(7)

MS Excel Spreadsheet, 118 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

For reports covering earlier years, when Zostavax® was in use, see Herpes zoster (shingles) immunisation programme 2023/24: evaluation reports.